Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kun Yu

Showing results (991-1000 of 1,009) with videos related to

Pageof 101
Sort By:
Cancer Research|September 6, 2014
Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokersVidhya G Krishnan, Philip J Ebert, Jason C Ting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trialCheng Xu, Si-Yang Wang, Man Nie, et al.
Nature Medicine|April 29, 2020
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancerYou Lu, Jianxin Xue, Tao Deng, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancerYou Lu, Jianxin Xue, Tao Deng, et al.
Nature Medicine|April 21, 2015
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomesRazvan Cristescu, Jeeyun Lee, Michael Nebozhyn, et al.
Cancer Discovery|June 1, 2018
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with <i>FGFR3</i> AlterationsSumanta K Pal, Jonathan E Rosenberg, Jean H Hoffman-Censits, et al.
Cancer Cell|January 19, 2024
Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinomaXiao-Jing Du, Gao-Yuan Wang, Xiao-Dong Zhu, et al.
Cancers|January 28, 2026
Technology-Enabled (P)rehabilitation for Patients Undergoing Cancer Surgery: A Systematic Review and Meta-AnalysisTiffany R Tsoukalas, Zirong Bai, Claire Jeon, et al.
Leukemia|June 26, 2021
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasmsDavid P Steensma, Martin Wermke, Virginia M Klimek, et al.
Cancer Communications (London, England)|October 26, 2021
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinomaLing-Long Tang, Yu-Pei Chen, Chuan-Ben Chen, et al.
Pageof 101

Showing results (991-1000 of 1,009) with videos related to

Sort By:
Pageof 101
Cancer Research|September 6, 2014
Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokersVidhya G Krishnan, Philip J Ebert, Jason C Ting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trialCheng Xu, Si-Yang Wang, Man Nie, et al.
Nature Medicine|April 29, 2020
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancerYou Lu, Jianxin Xue, Tao Deng, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancerYou Lu, Jianxin Xue, Tao Deng, et al.
Nature Medicine|April 21, 2015
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomesRazvan Cristescu, Jeeyun Lee, Michael Nebozhyn, et al.
Cancer Discovery|June 1, 2018
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with <i>FGFR3</i> AlterationsSumanta K Pal, Jonathan E Rosenberg, Jean H Hoffman-Censits, et al.
Cancer Cell|January 19, 2024
Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinomaXiao-Jing Du, Gao-Yuan Wang, Xiao-Dong Zhu, et al.
Cancers|January 28, 2026
Technology-Enabled (P)rehabilitation for Patients Undergoing Cancer Surgery: A Systematic Review and Meta-AnalysisTiffany R Tsoukalas, Zirong Bai, Claire Jeon, et al.
Leukemia|June 26, 2021
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasmsDavid P Steensma, Martin Wermke, Virginia M Klimek, et al.
Cancer Communications (London, England)|October 26, 2021
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinomaLing-Long Tang, Yu-Pei Chen, Chuan-Ben Chen, et al.
Pageof 101